Ligand
LGND

Ligand (LGND) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysInitiated CoverageOverweight$345.00Sep 25, 2026
HC Wainwright & Co.MaintainedBuy$358.00Sep 24, 2026
CitigroupMaintainedBuy$397.00 from $390.00Sep 23, 2026
Leerink PartnersInitiated CoverageOutperform$330.00Aug 14, 2026
RBC CapitalMaintainedOutperform$345.00 from $340.00Aug 7, 2026
HC Wainwright & Co.MaintainedBuy$358.00 from $289.00Aug 6, 2026
OppenheimerMaintainedOutperform$326.00 from $285.00Aug 3, 2026
CitigroupMaintainedBuy$387.00Jul 21, 2026
RBC CapitalMaintainedOutperform$340.00 from $262.00Jul 15, 2026
B of A SecuritiesMaintainedBuy$388.00 from $266.00Jul 9, 2026
StifelMaintainedBuy$332.00 from $255.00Jul 8, 2026
RBC CapitalMaintainedOutperform$262.00 from $252.00May 8, 2026
HC Wainwright & Co.MaintainedBuy$289.00 from $243.00Apr 30, 2026
RBC CapitalMaintainedOutperform$252.00 from $235.00Apr 28, 2026
CitigroupMaintainedBuy$282.00 from $276.00Apr 15, 2026
HC Wainwright & Co.MaintainedBuy$243.00 from $239.00Apr 14, 2026
CitigroupMaintainedBuy$276.00 from $270.00Mar 24, 2026
B of A SecuritiesInitiated CoverageBuy$244.00Mar 11, 2026
OppenheimerMaintainedOutperform$277.00 from $275.00Feb 27, 2026
HC Wainwright & Co.MaintainedBuy$239.00 from $231.00Feb 24, 2026

Frequently asked questions

  • What is the latest analyst rating on LGND?

    On Sep 25, 2026, Barclays initiated coverage of Ligand at Overweight with a price target of $345.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.